Webinars - Neurology

Webinars - Neurology

Webinar Date:
Danielle Graham, PhD from Biogen presented on accelerating exploratory fluid biomarker assay development in neurodegenerative disease at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
Cheryl Wellington, PhD from the University of British Columbia, presented on the functional modeling of the human cerebrovasculature at the inaugural Powering Precision Health Summit 2016.
Hosted by Cambridge Healthtech Institute
Webinar Date:
Hosted by Cambridge Healthtech Institute, this webinar will describe how blood biomarkers can be used to detect CNS disorders.
Webinar Date:
In this seminar, we will discuss the particularly striking results from our recent study of NfL in Huntington's disease and why we think it has real potential to change the course of therapeutic development in HD and other neurogenerative diseases.
Webinar Date:
Miriam Moscovitch-Lopatin, from MassGeneral Institute for Neurodegenerative Disease presented a longitudinal pre-cell biomarker study she conducted on an ultrasensitive Simoa immunoassay for quantifying BDNF levels in cerebral spinal fluid in early Huntington's disease at the inaugural Powering P
December 2, 2016
Webinar Date:
Hosted by Cambridge Healthtech Institute, this webinar will highlight the use of a Simoa custom assay and the commercial tau assay for different applications in mouse and human studies.
Webinar Date:
Alison Joyce from Pfizer, Inc. presented her research on the development of a sensitive homebrew Simoa assay to detect Leucine-rich repeat Kinase 2 (LRRK2) at the inaugural Powering Precision Health Summit 2016.
Nature.com Webcast
Webinar Date:
Speaker:  Dan Sikkema, PhD, Vice President Biomarker Services, QuanterixModerator: Dr. Jayshan Carpen, Moderator, Nature Research
Webinar Date:
Jessica Gill, PhD, RN, from the National Institute of Health, presented her research on the role of proteomic biomarkers of brain injuries at the inaugural Powering Precision Health Summit 2016.
Webinar Date:
TBIs are common in military personnel and civilians, placing these individuals at high risk for neurological deficits. The reasons why some individuals are at higher risk for these symptoms and deficits remains largely unknown. This webinar explores the topic further.